Apex Labs Granted Approval for 160 Patient Macrodose Multi-Dose Psilocybin Clinical Trial by Health Canada04.20.23Cision Canada Read more
Apex Labs Meets Endpoints in First-of-its-Kind Take Home Microdose Psilocybin Clinical Trial03.29.23Cision Read more
Apex Labs Granted Approval for 294 Patient Take Home Psilocybin Clinical Trial01.19.23Cision Read more
Apex Labs Granted Approval for North America’s First Take Home Psilocybin Clinical Trial11.01.22Cision Canada Read more
Health Canada Approves First Special Access Program Requests for Psilocybin04.08.22TheraPsil Read more
Apex Labs granted phase 2a Clinical Trial Application approval by Health Canada for treatment of PTSD in Veterans03.08.22Cision Canada Read more
Apex files phase 2a Clinical Trial Application (“CTA”) with Health Canada and announces Series A financing02.09.22Cision Canada Read more